Frontlight ResearchEarly access
Trial site
Pamukkale University Medical Faculty
- 2running trials
- 3closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma3 trials
- Acute myeloid leukaemia1 trial
- Bladder cancer1 trial
- Chronic lymphocytic leukaemia1 trial
- Chronic myeloid leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- High blood pressure1 trial
- Mantle cell lymphoma1 trial
- Psoriasis1 trial
- Psoriatic arthritis1 trial
- Pulmonary arterial hypertension1 trial
- Phase
- Phase 34 trials
- Phase 41 trial
- Status
- Active, not recruiting2 trials
- Completed2 trials
- Terminated1 trial
- Lead sponsor
- Janssen Research & Development, LLC3 trials
- Actelion1 trial
- Pharmacyclics Switzerland GmbH1 trial
Running trials
Active, not recruiting
Active, not recruiting
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
Closed trials
Recruiting
Completed
Terminated
Site data: ClinicalTrials.govUpdated 12 Nov 2026